Appendiceal Adenocarcinoma clinical trials at UCSF
1 research study open to eligible people
Appendiceal adenocarcinoma is a type of cancer. UCSF is conducting a clinical trial called "SGN-STNV in Advanced Solid Tumors" to test a drug for patients with solid tumors. The trial will study the drug to see if it is safe and what side effects it may have.
A Study of SGN-STNV in Advanced Solid Tumors
open to eligible people ages 18 years and up
This trial will look at a drug called SGN-STNV to find out whether it is safe for patients with solid tumors. It will study SGN-STNV to find out what its side effects are. A side effect is anything the drug does besides treating cancer. It will also study how well SGN-STNV works to treat solid tumors. The study will have two parts. Part A of the study will find out how much SGN-STNV should be given to patients. Part B will use the dose found in Part A to find out how safe SGN-STNV is and if it works to treat certain types of solid tumors.
San Francisco, California and other locations
Our lead scientists for Appendiceal Adenocarcinoma research studies include Pamela Munster.